The sample set consisted of 67 primary and recurrent tumors from 13 BRCA1/2 germline mutation carriers with breast cancer and 14 BRCA1/2 germline mutation carriers with ovarian cancer. This evidence concerns the gene BRCA1 and breast carcinoma.